Nigericin decreases the viability of multidrug-resistant cancer cells and lung tumorspheres and potentiates the effects of cardiac glycosides

by Juan Sebastian Yakisich, Neelam Azad, Vivek Kaushik, George A O’Doherty, Anand Krishnan V Iyer
Published 2017-03-01

Identifying requirements for RSK2 specific inhibitors

by Eric B. Wright, Shinji Fukuda, Mingzong Li, Yu Li, George A. O’Doherty, Deborah A. Lannigan
Published 2021-01-01